|
Q3 2024
|
182 |
7,486,958 |
NVDA, MSFT, GLOB, HEI
|
13F-HR
|
10/15/2024 |
000111232524000010 |
|
Q2 2024
|
178 |
7,359,057 |
MSFT, NVDA, GLOB, LOPE
|
13F-HR
|
7/17/2024 |
000111232524000008 |
|
Q1 2024
|
174 |
8,195,997 |
GLOB, MSFT, RBA.TO, MEDP
|
13F-HR
|
4/26/2024 |
000111232524000007 |
|
Q4 2023
|
202 |
8,004,609 |
GLOB, FIVE, LOPE, RBA.TO
|
RESTATEMENT
|
2/15/2024 |
000111232524000005 |
|
Q3 2023
|
192 |
7,327,554 |
GLOB, RBA.TO, FIVE, LOPE
|
RESTATEMENT
|
2/15/2024 |
000111232524000006 |
|
Q2 2023
|
192 |
7,932,423 |
FIVE, GLOB, RBA.TO, CSGP
|
13F-HR
|
7/25/2023 |
000111232523000007 |
|
Q1 2023
|
189 |
7,133,675 |
FIVE, RBA, GLOB, LOPE
|
13F-HR
|
4/21/2023 |
000111232523000006 |
|
Q4 2022
|
195 |
6,660,714 |
FIVE, RBA, GLOB, LOPE
|
13F-HR
|
1/11/2023 |
000111232523000001 |
|
Q3 2022
|
194 |
6,734,741 |
GLOB, RBA, FIVE, PCTY
|
13F-HR
|
10/26/2022 |
000111232522000012 |
|
Q2 2022
|
195 |
6,247,594 |
RBA, GLOB, LOPE, MSFT
|
NEW HOLDINGS
|
8/29/2022 |
000111232522000010 |
|
Q2 2022
|
162 |
6,989,953 |
RBA, GLOB, LOPE, MSFT
|
13F-HR
|
7/11/2022 |
000111232522000009 |
|
Q1 2022
|
161 |
8,848,699 |
GLOB, AMED, LOPE, RBA
|
13F-HR
|
4/20/2022 |
000111232522000008 |
|
Q4 2021
|
168 |
10,111,618 |
GLOB, FIVE, WST, RBA
|
13F-HR
|
1/14/2022 |
000111232522000001 |
|
Q3 2021
|
156 |
9,974,178 |
GLOB, RBA, FIVE, WST
|
13F-HR
|
10/26/2021 |
000111232521000010 |
|
Q2 2021
|
157 |
9,848,233 |
GLOB, FIVE, RBA, LOPE
|
13F-HR
|
7/26/2021 |
000111232521000008 |
|
Q1 2021
|
153 |
8,779,553 |
GLOB, LOPE, FIVE, RBA
|
13F-HR
|
4/21/2021 |
000111232521000006 |
|
Q4 2020
|
152 |
9,052,485 |
GLOB, BL, FIVE, RBA
|
13F-HR
|
1/22/2021 |
000111232521000001 |
|
Q3 2020
|
148 |
7,165,239 |
GLOB, RBA, FIVE, PRLB
|
13F-HR
|
10/8/2020 |
000111232520000008 |
|
Q2 2020
|
148 |
6,371,627 |
GLOB, PRLB, CSGP, LOPE
|
13F-HR
|
7/8/2020 |
000111232520000007 |
|
Q1 2020
|
137 |
4,776,971 |
CHE, CSGP, TDOC, LOPE
|
13F-HR
|
4/13/2020 |
000111232520000005 |
|
Q4 2019
|
138 |
5,569,937 |
LOPE, CHE, PRLB, CSGP
|
13F-HR
|
1/14/2020 |
000111232520000002 |
|
Q3 2019
|
134 |
5,277,498 |
PRLB, CHE, CSGP, RBA
|
13F-HR
|
10/11/2019 |
000111232519000010 |
|
Q2 2019
|
136 |
5,286,256 |
PRLB, CSGP, GLOB, LOPE
|
13F-HR
|
7/10/2019 |
000111232519000009 |
|
Q1 2019
|
132 |
5,149,136 |
ULTI, PRLB, HEI, RBA
|
13F-HR
|
4/4/2019 |
000111232519000007 |
|
Q4 2018
|
131 |
4,795,632 |
PRLB, RBA, NATI, HCSG
|
13F-HR
|
1/14/2019 |
000111232519000002 |
|
Q3 2018
|
131 |
5,981,192 |
PRLB, ULTI, RBA, HEI
|
13F-HR
|
10/3/2018 |
000111232518000016 |
|
Q2 2018
|
128 |
5,547,528 |
PRLB, FIVE, RBA, CHE
|
13F-HR
|
7/3/2018 |
000111232518000015 |
|
Q1 2018
|
133 |
5,476,174 |
LOPE, PRLB, NATI, ULTI
|
13F-HR
|
4/3/2018 |
000111232518000013 |
|
Q4 2017
|
138 |
5,171,183 |
LOPE, PRLB, RBA, ULTI
|
13F-HR
|
1/24/2018 |
000111232518000002 |
|
Q3 2017
|
139 |
5,077,162 |
LOPE, CSGP, HCSG, PRLB
|
13F-HR
|
11/1/2017 |
000111232517000021 |
|
Q2 2017
|
139 |
5,229,107 |
NATI, LOPE, CSGP, ULTI
|
13F-HR
|
7/24/2017 |
000111232517000020 |
|
Q1 2017
|
135 |
4,978,922 |
LOPE, NATI, ULTI, CSGP
|
13F-HR
|
4/25/2017 |
000111232517000018 |
|
Q4 2016
|
133 |
4,787,977 |
NATI, LOPE, ULTI, GNTX
|
13F-HR
|
1/20/2017 |
000111232517000001 |
|
Q3 2016
|
131 |
4,996,718 |
CPHD, ULTI, CSGP, NATI
|
13F-HR
|
10/24/2016 |
000111232516000058 |
|
Q2 2016
|
133 |
4,823,971 |
ULTI, CSGP, RBA, HCSG
|
13F-HR
|
8/1/2016 |
000111232516000057 |
|
Q1 2016
|
135 |
4,800,718 |
ULTI, CSGP, PRLB, LOPE
|
13F-HR
|
4/27/2016 |
000111232516000053 |
|
Q4 2015
|
138 |
4,866,828 |
ULTI, CSGP, athenahealth, Inc., BECN
|
13F-HR
|
1/28/2016 |
000111232516000030 |
|
Q3 2015
|
135 |
4,852,721 |
ULTI, CPHD, athenahealth, Inc., CSGP
|
13F-HR
|
10/23/2015 |
000111232515000028 |
|
Q2 2015
|
134 |
5,302,830 |
CPHD, ULTI, Dealertrack Technologies, Inc., CSGP
|
13F-HR
|
7/20/2015 |
000111232515000027 |
|
Q1 2015
|
131 |
5,560,396 |
CPHD, ULTI, CSGP, NATI
|
13F-HR
|
4/23/2015 |
000111232515000025 |
|
Q4 2014
|
129 |
5,380,161 |
CPHD, ULTI, RBA, CSGP
|
13F-HR
|
1/20/2015 |
000111232515000002 |
|
Q3 2014
|
128 |
5,129,770 |
CPHD, ULTI, NATI, Athenahealth Inc.
|
13F-HR
|
11/5/2014 |
000111232514000029 |
|
Q2 2014
|
131 |
5,736,693 |
CPHD, ULTI, NATI, PRAA
|
13F-HR
|
7/31/2014 |
000111232514000028 |
|
Q1 2014
|
128 |
5,525,354 |
CPHD, ULTI, PRAA, RBA
|
13F-HR
|
5/9/2014 |
000111232514000025 |
|
Q4 2013
|
126 |
5,515,275 |
CPHD, ULTI, NATI, CSGP
|
13F-HR
|
2/10/2014 |
000111232514000024 |